166 related articles for article (PubMed ID: 16688684)
1. Potential tuberculostatic agent: micelle-forming pyrazinamide prodrug.
Silva M; Ricelli NL; El Seoud O; Valentim CS; Ferreira AG; Sato DN; Leite CQ; Ferreira EI
Arch Pharm (Weinheim); 2006 Jun; 339(6):283-90. PubMed ID: 16688684
[TBL] [Abstract][Full Text] [Related]
2. Potential tuberculostatic agents: micelle-forming copolymer poly(ethylene glycol)-poly(aspartic acid) prodrug with isoniazid.
Silva M; Lara AS; Leite CQ; Ferreira EI
Arch Pharm (Weinheim); 2001 Jun; 334(6):189-93. PubMed ID: 11475908
[TBL] [Abstract][Full Text] [Related]
3. Lipophilic pyrazinoic acid amide and ester prodrugs stability, activation and activity against M. tuberculosis.
Simões MF; Valente E; Gómez MJ; Anes E; Constantino L
Eur J Pharm Sci; 2009 Jun; 37(3-4):257-63. PubMed ID: 19491013
[TBL] [Abstract][Full Text] [Related]
4. QSAR modeling of a set of pyrazinoate esters as antituberculosis prodrugs.
Fernandes JP; Pasqualoto KF; Felli VM; Ferreira EI; Brandt CA
Arch Pharm (Weinheim); 2010 Feb; 343(2):91-7. PubMed ID: 20099263
[TBL] [Abstract][Full Text] [Related]
5. Shell-cross-linked amino acid-modified APLA-b-PEG-Cys copolymer micelle as a drug delivery carrier.
Xu B; Yuan J; Wang Z; Gao Q
J Microencapsul; 2009 Nov; 26(7):659-66. PubMed ID: 19839802
[TBL] [Abstract][Full Text] [Related]
6. Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis.
Zimhony O; Cox JS; Welch JT; Vilchèze C; Jacobs WR
Nat Med; 2000 Sep; 6(9):1043-7. PubMed ID: 10973326
[TBL] [Abstract][Full Text] [Related]
7. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles.
Forrest ML; Zhao A; Won CY; Malick AW; Kwon GS
J Control Release; 2006 Nov; 116(2):139-49. PubMed ID: 16926059
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
Aragón LM; Garrigó M; Moreno C; Español M; Coll P
J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable cationic PEG-PEI-PBLG hyperbranched block copolymer: synthesis and micelle characterization.
Tian HY; Deng C; Lin H; Sun J; Deng M; Chen X; Jing X
Biomaterials; 2005 Jul; 26(20):4209-17. PubMed ID: 15683643
[TBL] [Abstract][Full Text] [Related]
10. PEGylated chitosan-based polymer micelle as an intracellular delivery carrier for anti-tumor targeting therapy.
Hu FQ; Meng P; Dai YQ; Du YZ; You J; Wei XH; Yuan H
Eur J Pharm Biopharm; 2008 Nov; 70(3):749-57. PubMed ID: 18620050
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of amphiphilic poly(ether-amide) dendrimer endcapped with poly(ethylene glycol) grafts and its solubilization to salicylic acid.
Yang Z; Zhang W; Liu J; Shi W
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):229-34. PubMed ID: 17234394
[TBL] [Abstract][Full Text] [Related]
12. [Nutrient starved incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis].
Chen ZF; Huang Q; Li YY; Zhang Y; Ren Y; Li KS; Fu ZJ; Xu SQ
Zhonghua Jie He He Hu Xi Za Zhi; 2007 May; 30(5):359-62. PubMed ID: 17651643
[TBL] [Abstract][Full Text] [Related]
13. Iron hydroxide nanoparticles coated with poly(ethylene glycol)-poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging.
Kumagai M; Imai Y; Nakamura T; Yamasaki Y; Sekino M; Ueno S; Hanaoka K; Kikuchi K; Nagano T; Kaneko E; Shimokado K; Kataoka K
Colloids Surf B Biointerfaces; 2007 Apr; 56(1-2):174-81. PubMed ID: 17324561
[TBL] [Abstract][Full Text] [Related]
14. Antimycobacterial activity of pyrazinoate prodrugs in replicating and non-replicating Mycobacterium tuberculosis.
Segretti ND; Simões CK; Corrêa MF; Felli VMA; Miyata M; Cho SH; Franzblau SG; Fernandes JPDS
Tuberculosis (Edinb); 2016 Jul; 99():11-16. PubMed ID: 27449999
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antimycobacterial and antifungal evaluation of 3-arylaminopyrazine-2,5-dicarbonitriles.
Palek L; Dvorák J; Svobodová M; Buchta V; Jampílek J; Dolezal M
Arch Pharm (Weinheim); 2008 Jan; 341(1):61-5. PubMed ID: 18072243
[TBL] [Abstract][Full Text] [Related]
16. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid.
Zhang Y; Wade MM; Scorpio A; Zhang H; Sun Z
J Antimicrob Chemother; 2003 Nov; 52(5):790-5. PubMed ID: 14563891
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs.
Sezgin Z; Yüksel N; Baykara T
Eur J Pharm Biopharm; 2006 Nov; 64(3):261-8. PubMed ID: 16884896
[TBL] [Abstract][Full Text] [Related]
18. Metalated diblock and triblock poly(ethylene oxide)-block-poly(4-vinylpyridine) copolymers: understanding of micelle and bulk structure.
Bronstein LM; Sidorov SN; Zhirov V; Zhirov D; Kabachii YA; Kochev SY; Valetsky PM; Stein B; Kiseleva OI; Polyakov SN; Shtykova EV; Nikulina EV; Svergun DI; Khokhlov AR
J Phys Chem B; 2005 Oct; 109(40):18786-98. PubMed ID: 16853418
[TBL] [Abstract][Full Text] [Related]
19. Poly(ethylene glycol)-conjugated phospholipids in aqueous micellar solutions: hydration, static structure, and interparticle interactions.
Sato T; Sakai H; Sou K; Buchner R; Tsuchida E
J Phys Chem B; 2007 Feb; 111(6):1393-401. PubMed ID: 17286354
[TBL] [Abstract][Full Text] [Related]
20. [Pyrazinamide monoresistant Mycobacterium tuberculosis in Manisa region, Turkey].
Ozkütük N; Ecemiş T; Sürücüoğlu S
Mikrobiyol Bul; 2008 Oct; 42(4):585-90. PubMed ID: 19149079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
